Article
Phase-separated nuclear bodies of nucleoporin fusions, SET-NUP214 and NUP98-HOXA9, promote…
medRxiv · 2022 · Masahiro Oka
Key facts
| Title | Phase-separated nuclear bodies of nucleoporin fusions, SET-NUP214 and NUP98-HOXA9, promote condensation of MLL1 and CRM1 to activate target genes |
|---|---|
| First author | Masahiro Oka |
| Journal | medRxiv |
| Published | May 24, 2022 |
| DOI | 10.1101/2022.05.24.493212 |
| Devices mentioned | BK110039, K073490, K123955 |
| Product codes mentioned | CFN, JJH, KIT, NJT, OOI, PFF, PFT, PPM, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1